Perry C. Siatis
CIK: 0001951400
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbbVie Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Mar 2, 2026ABBV
AbbVie Inc.
Sale(S)Direct2.6K shares at avg. $235.26$612K - Mar 2, 2026ABBV
AbbVie Inc.
Sale(S)Direct5.8K shares at avg. $233.51$1.3M - Mar 2, 2026ABBV
AbbVie Inc.
Sale(S)Direct10.3K shares at avg. $234.66$2.4M - Feb 27, 2026ABBV
AbbVie Inc.
Tax Payment(F)Direct14.9K shares at avg. $232.08$3.4M - Feb 25, 2026ABBV
AbbVie Inc.
Exercise(M)Direct7.3K shares at avg. $149.62$1.1M - Feb 25, 2026ABBV
AbbVie Inc.
Exercise(M)Direct7.3K shares at avg. $192.86$1.4M - Feb 25, 2026ABBV
AbbVie Inc.
Exercise(M)Direct7.8K shares at avg. $175.28$1.4M - Feb 25, 2026ABBV
AbbVie Inc.
Sale(S)Direct22.4K shares at avg. $230.00$5.1M - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct5.8K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct5.8K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct16.3K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct5.6K shares- - Mar 3, 2025ABBV
AbbVie Inc.
Disposition(D)DirectOption (Right to buy)
7.8K shares at avg. $175.28- - Mar 3, 2025ABBV
AbbVie Inc.
Exercise(M)Direct2.9K shares at avg. $144.54$422K - Mar 3, 2025ABBV
AbbVie Inc.
Exercise(M)Direct7.3K shares at avg. $149.62$1.1M - Mar 3, 2025ABBV
AbbVie Inc.
Exercise(M)Direct7.8K shares at avg. $175.28$1.4M - Mar 3, 2025ABBV
AbbVie Inc.
Sale(S)Direct18K shares at avg. $210.00$3.8M - Mar 3, 2025ABBV
AbbVie Inc.
Disposition(D)DirectOption (Right to buy)
2.9K shares at avg. $144.54- - Mar 3, 2025ABBV
AbbVie Inc.
Disposition(D)DirectOption (Right to buy)
7.3K shares at avg. $149.62- - Feb 28, 2025ABBV
AbbVie Inc.
Sale(S)Direct2.7K shares at avg. $205.38$558K - Feb 28, 2025ABBV
AbbVie Inc.
Tax Payment(F)Direct7.9K shares at avg. $205.02$1.6M - Feb 28, 2025ABBV
AbbVie Inc.
Sale(S)Direct363 shares at avg. $207.19$75K - Feb 28, 2025ABBV
AbbVie Inc.
Sale(S)Direct6.8K shares at avg. $206.62$1.4M - Feb 20, 2025ABBV
AbbVie Inc.
Sale(S)Direct4K shares at avg. $198.12$791K - Feb 20, 2025ABBV
AbbVie Inc.
Sale(S)Direct1.8K shares at avg. $197.40$352K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | ABBV AbbVie Inc. | Sale(S) | 2,600 | $235.26 | $611,676 | Direct |
| Mar 2, 2026 | ABBV AbbVie Inc. | Sale(S) | 5,777 | $233.51 | $1,348,987 | Direct |
| Mar 2, 2026 | ABBV AbbVie Inc. | Sale(S) | 10,291 | $234.66 | $2,414,886 | Direct |
| Feb 27, 2026 | ABBV AbbVie Inc. | Tax Payment(F) | 14,850 | $232.08 | $3,446,388 | Direct |
| Feb 25, 2026 | ABBV AbbVie Inc. | Exercise(M) | 7,314 | $149.62 | $1,094,321 | Direct |
| Feb 25, 2026 | ABBV AbbVie Inc. | Exercise(M) | 7,292 | $192.86 | $1,406,335 | Direct |
| Feb 25, 2026 | ABBV AbbVie Inc. | Exercise(M) | 7,775 | $175.28 | $1,362,802 | Direct |
| Feb 25, 2026 | ABBV AbbVie Inc. | Sale(S) | 22,381 | $230.00 | $5,147,630 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 5,808 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 5,792 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 16,290 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 5,628 | - | $0 | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Disposition(D) Option (Right to buy) | 7,775 | $175.28 | - | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Exercise(M) | 2,918 | $144.54 | $421,768 | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Exercise(M) | 7,315 | $149.62 | $1,094,470 | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Exercise(M) | 7,775 | $175.28 | $1,362,802 | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Sale(S) | 18,008 | $210.00 | $3,781,680 | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Disposition(D) Option (Right to buy) | 2,918 | $144.54 | - | Direct |
| Mar 3, 2025 | ABBV AbbVie Inc. | Disposition(D) Option (Right to buy) | 7,315 | $149.62 | - | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Sale(S) | 2,718 | $205.38 | $558,223 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Tax Payment(F) | 7,870 | $205.02 | $1,613,507 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Sale(S) | 363 | $207.19 | $75,210 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Sale(S) | 6,811 | $206.62 | $1,407,289 | Direct |
| Feb 20, 2025 | ABBV AbbVie Inc. | Sale(S) | 3,994 | $198.12 | $791,291 | Direct |
| Feb 20, 2025 | ABBV AbbVie Inc. | Sale(S) | 1,784 | $197.40 | $352,162 | Direct |
1-25 of 29 transactions
About Siatis Perry C
Siatis Perry C (SEC CIK 0001951400) files insider reports with the SEC as EVP, GC AND SECRETARY of AbbVie Inc. (ABBV).
Signal8 holds 6 ownership filings by Siatis Perry C, all Form 4s, filed between Feb 18, 2025 and Mar 3, 2026. Those filings report 29 transactions, from Feb 13, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Siatis Perry C's filings is in NORTH CHICAGO, IL.
Recent filings by Siatis Perry C
- Mar 2, 2026: Open-market sales of ABBV shares (3 lines, Form 4, code S).
- Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
- Feb 25, 2026: Option exercises of ABBV shares (3 lines, Form 4, code M).
- Feb 25, 2026: Open-market sale of ABBV shares (Form 4, code S).
- Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
Other insiders filing for AbbVie Inc. (ABBV)
- Carethers John, Director
- Quaggin Susan E, Director
- RAPP EDWARD J, Director
- Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER
- FALK THOMAS J, Director
- WADDELL FREDERICK H, Director